Abstract
Percutaneous mitral valve intervention (PMVI) has become an alternative therapeutic option for patients who are not eligible for conventional surgical treatment of mitral regurgitation (MR). PMVI can correct MR by means of the direct or indirect reduction of mitral annular dilatation, or through intervention on the primary or secondary abnormalities of the mitral apparatus. Among PMVI techniques, the MitraClip system, which is able to reproduce the edge-to-edge surgical procedure, is the only percutaneous therapeutic approach that can presently be considered clinically validated.
Original language | English |
---|---|
Title of host publication | Secondary Mitral Valve Regurgitation |
Publisher | Springer-Verlag London Ltd |
Pages | 153-164 |
Number of pages | 12 |
ISBN (Print) | 9781447164883, 9781447164876 |
DOIs | |
Publication status | Published - Jan 1 2015 |
ASJC Scopus subject areas
- Medicine(all)